A clinical review confirms that cannabinoid hyperemesis syndrome prevalence reaches approximately one-third of regular cannabis users. The condition presents with characteristic recurrent vomiting episodes and the distinctive finding of temporary relief with hot water exposure, making it an important consideration for clinicians managing cannabis patients.
Editorial: New York’s pot problem – Times Union
✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicySafetyMental Health Why This Matters Clinicians need to recognize that cannabis legalization can paradoxically increase...
Cannabis and Digestive Health: Clinical Risks – Medscape
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Cannabinoid Hyperemesis SyndromeGi EffectsThcAdverse EffectsClinical Recognition Why This MattersDigestive complications from cannabis use represent...
[Management of cannabinoid hyperemesis syndrome].
Cannabinoid hyperemesis syndrome (CHS) is a condition that affects approximately one-third of cannabis users. Symptoms include recurrent episodes of vomiting…
What Works—and What Doesn’t—When CVS and CHS Attacks Strike at Home or in the ER
More research is needed to develop evidence-based, individualized abortive treatment plans, as well as to determine whether the abortive treatment for CVS requires a fundamentally different approach than for CHS.
Expert Guidance on Treating Cyclic Vomiting and Cannabis Hyperemesis Episodes at Home and in the ER
Abortive therapies are more effective when taken at the earliest detected onset of an episode. Most patients with CVS have a discernable prodrome, with symptom onset presenting a median of ~50 min prior to the transition to the emetic phase.
Treating Cyclic Vomiting and Cannabinoid Hyperemesis: What the Evidence (and Experts) Currently Support
More research is needed to develop evidence-based, individualized abortive treatment plans, as well as to determine whether the abortive treatment for CVS requires a fundamentally different approach than for CHS.
Managing Cyclic Vomiting and Cannabis Hyperemesis Attacks: What the Evidence Says About Home and ER Treatment
An effective CVS management program hinges on taking abortive therapy at the first ‘inkling’ of symptom onset—ideally during the prodrome phase before vomiting has started. Most patients with CVS have a discernable prodrome, with symptom onset presenting a median of ~50 min prior to the transition to the emetic phase.
Prevalence and Correlates of Symptoms of Cannabinoid Hyperemesis Syndrome in the United States.
Cannabinoid Hyperemesis Syndrome (CHS) is an emerging condition among those with heavy cannabis use characterized by persistent and severe nausea and vomitin…
Spontaneous Pneumomediastinum and Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review.
We report the case of an 18-year-old man with a six-month history of chronic marijuana use who developed spontaneous pneumomediastinum (SPM) following multip…